Vertex Pharmaceuticals Inc. (VRTX)

Index:

Nasdaq 100

$ 396.12
   
  • Change Today:
    $-0.81
  • 52 Week High: $516.74
  • 52 Week Low: $374.46
  • Currency: US Dollars
  • Shares Issued: 256.94m
  • Volume: 1,171,303
  • Market Cap: $101,779m
  • RiskGrade: 164
  • Beta: 0.01

VRTX Overview

Vertex Pharmaceuticals Incorportated in a United States-based drug manufacturer. The company focuses on the research and development of small molecule drugs that are used in the treatment of diseases, including HIV infection & chronic hepatitis C virus.

Listings

Index: S&P 500, Nasdaq 100, Nasdaq Composite
ISIN: US92532F1003

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

VRTX Market Data

Currency US Dollars
Share Price $ 396.12
Change Today $ -0.81
% Change -0.20 %
52 Week High $516.74
52 Week Low $374.46
Volume 1,171,303
Shares Issued 256.94m
Market Cap $101,779m
Beta 0.01
RiskGrade 164

What The Brokers Say

Strong Buy 7
Buy 11
Neutral 10
Sell 1
Strong Sell 1
Total 30
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 05-Sep-2025

Time Volume / Share Price
15:59 100 @ $396.09
15:59 100 @ $395.98
15:59 100 @ $395.99
15:59 100 @ $395.98
15:59 100 @ $395.93

Top of Page